Lv11
10 积分 2023-01-28 加入
The present and future of bispecific antibodies for cancer therapy
1小时前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
1小时前
已完结
Renal Cell Carcinoma: New Developments in Molecular Biology and Potential for Targeted Therapies
4天前
已完结
Retrospective Analysis of the Safety and Efficacy of Interleukin-2 After Prior VEGF-targeted Therapy in Patients With Advanced Renal Cell Carcinoma
4天前
已完结
VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN HUMAN CHRONIC RENAL ALLOGRAFT REJECTION1
4天前
求助中
A Phase II Study of Bevacizumab and High-dose Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma
4天前
已完结
The biology of VEGF and its receptors
4天前
已完结
Structural motifs involved in human IgG antibody effector functions
5天前
已完结
TH2 cell development and function
20天前
已完结
Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade
1个月前
已完结
皖公网安备34019202002308
